{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "1769930",
  "DateCompleted": {
    "Year": "1992",
    "Month": "02",
    "Day": "21"
  },
  "DateRevised": {
    "Year": "2019",
    "Month": "05",
    "Day": "10"
  },
  "Article": {
    "ArticleDate": [],
    "Language": [
      "eng"
    ],
    "ELocationID": [],
    "Journal": {
      "ISSN": "0305-7453",
      "JournalIssue": {
        "Volume": "28",
        "Issue": "1",
        "PubDate": {
          "Year": "1991",
          "Month": "Jul"
        }
      },
      "Title": "The Journal of antimicrobial chemotherapy",
      "ISOAbbreviation": "J Antimicrob Chemother"
    },
    "ArticleTitle": "Aztreonam therapy in children with febrile neutropenia: a randomized trial of aztreonam plus flucloxacillin versus piperacillin plus gentamicin.",
    "Pagination": {
      "StartPage": "117",
      "EndPage": "129",
      "MedlinePgn": "117-29"
    },
    "Abstract": {
      "AbstractText": [
        "In a prospective, randomized trial in 100 febrile neutropenic children, aztreonam plus flucloxacillin was compared with piperacillin plus gentamicin. At the 72 h clinical assessment there was no statistically significant difference between the two groups. However, in microbiologically documented infections there was a higher response rate in the piperacillin/gentamicin group (57%) than in the aztreonam/flucoxacillin group (41%). This was contributed to by the poorer Gram-positive cover of the aztreonam/flucloxacillin combination. In clinically documented infections and unexplained fevers the response rate of the two antibiotic regimens was identical. There were two deaths; one early death (in the piperacillin/gentamicin arm) and one late death. At the final assessment a successful outcome was obtained in the remaining patients. In the aztreonam/flucloxacillin group 75% of the episodes required modification compared with 59% in the piperacillin/gentamicin group."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Paediatrics, St James's University Hospital, Leeds, UK."
          }
        ],
        "LastName": "Heney",
        "ForeName": "D",
        "Initials": "D"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Lewis",
        "ForeName": "I J",
        "Initials": "IJ"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Ghoneim",
        "ForeName": "A T",
        "Initials": "AT"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Chisholm",
        "ForeName": "P",
        "Initials": "P"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Bailey",
        "ForeName": "C C",
        "Initials": "CC"
      }
    ],
    "PublicationTypeList": [
      "Clinical Trial",
      "Journal Article",
      "Randomized Controlled Trial"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "England",
    "MedlineTA": "J Antimicrob Chemother",
    "NlmUniqueID": "7513617",
    "ISSNLinking": "0305-7453"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Gentamicins"
    },
    {
      "RegistryNumber": "43B2M34G2V",
      "NameOfSubstance": "Floxacillin"
    },
    {
      "RegistryNumber": "G2B4VE5GH8",
      "NameOfSubstance": "Aztreonam"
    },
    {
      "RegistryNumber": "X00B0D5O0E",
      "NameOfSubstance": "Piperacillin"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Adolescent"
    },
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Aztreonam"
    },
    {
      "QualifierName": [
        "complications",
        "drug therapy"
      ],
      "DescriptorName": "Bacteremia"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Child"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Child, Preschool"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Drug Therapy, Combination"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Female"
    },
    {
      "QualifierName": [
        "complications",
        "drug therapy"
      ],
      "DescriptorName": "Fever"
    },
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Floxacillin"
    },
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Gentamicins"
    },
    {
      "QualifierName": [
        "drug effects"
      ],
      "DescriptorName": "Gram-Negative Bacteria"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Infant"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Male"
    },
    {
      "QualifierName": [
        "complications",
        "drug therapy"
      ],
      "DescriptorName": "Neutropenia"
    },
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Piperacillin"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Prospective Studies"
    }
  ]
}